Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Renin-Angiotensin System | 12 | 2021 | 3661 | 2.37 | Why? |
| Urethral Diseases | 2 | 2018 | 5 | 1.45 | Why? |
| Urethra | 2 | 2018 | 47 | 1.37 | Why? |
| Angiotensin II | 4 | 2018 | 601 | 1.14 | Why? |
| Kidney Diseases | 3 | 2021 | 1434 | 1.12 | Why? |
| Fetus | 2 | 2018 | 484 | 1.05 | Why? |
| Nitric Oxide | 2 | 2019 | 769 | 0.91 | Why? |
| Trypanosoma cruzi | 2 | 2019 | 133 | 0.88 | Why? |
| Urogenital Abnormalities | 1 | 2018 | 10 | 0.79 | Why? |
| Vesico-Ureteral Reflux | 1 | 2018 | 17 | 0.78 | Why? |
| Angiotensin I | 2 | 2018 | 200 | 0.77 | Why? |
| Chagas Cardiomyopathy | 1 | 2019 | 50 | 0.76 | Why? |
| DNA Copy Number Variations | 1 | 2018 | 84 | 0.75 | Why? |
| Urinary Tract | 1 | 2018 | 77 | 0.73 | Why? |
| Albuminuria | 1 | 2019 | 164 | 0.72 | Why? |
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2017 | 8 | 0.70 | Why? |
| Proteinuria | 3 | 2017 | 474 | 0.68 | Why? |
| Chagas Disease | 1 | 2019 | 155 | 0.65 | Why? |
| Peptidyl-Dipeptidase A | 9 | 2021 | 9659 | 0.63 | Why? |
| Chemokines | 3 | 2019 | 1095 | 0.63 | Why? |
| Infant, Extremely Premature | 1 | 2017 | 144 | 0.62 | Why? |
| Neurocognitive Disorders | 1 | 2017 | 99 | 0.61 | Why? |
| Cytokines | 7 | 2019 | 15010 | 0.59 | Why? |
| Central Nervous System Diseases | 1 | 2021 | 410 | 0.58 | Why? |
| Nephrotic Syndrome | 1 | 2017 | 146 | 0.58 | Why? |
| Peptide Fragments | 4 | 2018 | 2075 | 0.57 | Why? |
| Infant, Premature | 2 | 2017 | 883 | 0.51 | Why? |
| Anemia, Sickle Cell | 1 | 2019 | 546 | 0.48 | Why? |
| Interleukin-1beta | 1 | 2017 | 992 | 0.46 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2021 | 1731 | 0.44 | Why? |
| Hepatitis B, Chronic | 1 | 2017 | 616 | 0.43 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 4 | 2021 | 5277 | 0.42 | Why? |
| Liver Cirrhosis | 2 | 2017 | 1810 | 0.38 | Why? |
| Biomarkers | 10 | 2019 | 23361 | 0.36 | Why? |
| Killer Cells, Natural | 1 | 2017 | 2093 | 0.33 | Why? |
| Kidney | 2 | 2018 | 3648 | 0.33 | Why? |
| Chemokine CCL2 | 2 | 2019 | 389 | 0.33 | Why? |
| Myocardium | 1 | 2019 | 2323 | 0.32 | Why? |
| Morphine | 1 | 2006 | 71 | 0.32 | Why? |
| Inflammation Mediators | 2 | 2017 | 2654 | 0.32 | Why? |
| Renal Insufficiency, Chronic | 2 | 2017 | 2654 | 0.30 | Why? |
| Rats, Sprague-Dawley | 2 | 2019 | 987 | 0.30 | Why? |
| Respiratory Distress Syndrome, Newborn | 1 | 2006 | 124 | 0.30 | Why? |
| Glomerulonephritis, IGA | 2 | 2017 | 115 | 0.29 | Why? |
| Brain | 2 | 2019 | 5133 | 0.27 | Why? |
| Interleukin-8 | 2 | 2019 | 964 | 0.24 | Why? |
| Adolescent, Hospitalized | 1 | 2021 | 9 | 0.23 | Why? |
| Liver Diseases | 1 | 2017 | 2698 | 0.22 | Why? |
| Physicians | 1 | 2020 | 4214 | 0.21 | Why? |
| Piperidines | 1 | 2006 | 795 | 0.20 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.20 | Why? |
| NG-Nitroarginine Methyl Ester | 1 | 2019 | 6 | 0.20 | Why? |
| Nitric Oxide Synthase | 1 | 2019 | 37 | 0.20 | Why? |
| Pregnancy | 5 | 2021 | 23879 | 0.19 | Why? |
| Chemokine CXCL9 | 1 | 2019 | 154 | 0.19 | Why? |
| Chromosome Deletion | 1 | 2018 | 62 | 0.19 | Why? |
| Interleukin-12 | 1 | 2019 | 156 | 0.18 | Why? |
| Kidney Failure, Chronic | 4 | 2019 | 3222 | 0.18 | Why? |
| Immunosorbent Techniques | 1 | 2018 | 35 | 0.18 | Why? |
| Glomerular Mesangium | 1 | 2017 | 5 | 0.18 | Why? |
| Hyaluronan Receptors | 1 | 2017 | 61 | 0.17 | Why? |
| Nerve Growth Factors | 1 | 2017 | 30 | 0.17 | Why? |
| Hepatorenal Syndrome | 1 | 2017 | 26 | 0.17 | Why? |
| Endocytosis | 1 | 2021 | 451 | 0.17 | Why? |
| Child, Hospitalized | 1 | 2021 | 556 | 0.17 | Why? |
| Complement C4b | 1 | 2017 | 57 | 0.16 | Why? |
| Inflammation | 5 | 2021 | 13255 | 0.16 | Why? |
| Analgesics, Opioid | 1 | 2006 | 1070 | 0.16 | Why? |
| Child | 10 | 2021 | 70012 | 0.16 | Why? |
| Glomerulosclerosis, Focal Segmental | 1 | 2017 | 104 | 0.16 | Why? |
| Maternal Age | 1 | 2017 | 244 | 0.15 | Why? |
| Kidney Glomerulus | 1 | 2017 | 144 | 0.15 | Why? |
| Databases, Factual | 2 | 2021 | 6248 | 0.15 | Why? |
| INDEL Mutation | 1 | 2016 | 128 | 0.15 | Why? |
| Factor VIII | 1 | 2017 | 229 | 0.15 | Why? |
| Plasminogen Activator Inhibitor 1 | 1 | 2016 | 162 | 0.14 | Why? |
| Chemokine CXCL10 | 1 | 2019 | 565 | 0.14 | Why? |
| Kidney Function Tests | 1 | 2017 | 520 | 0.14 | Why? |
| Brain Injuries, Traumatic | 1 | 2020 | 381 | 0.14 | Why? |
| Transforming Growth Factor beta1 | 1 | 2016 | 204 | 0.14 | Why? |
| Humans | 29 | 2021 | 930598 | 0.14 | Why? |
| Down-Regulation | 1 | 2021 | 1416 | 0.14 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.13 | Why? |
| Animals | 6 | 2021 | 78931 | 0.13 | Why? |
| Fibrosis | 1 | 2017 | 800 | 0.13 | Why? |
| Dyslipidemias | 1 | 2019 | 791 | 0.12 | Why? |
| Interleukin-10 | 1 | 2019 | 1409 | 0.12 | Why? |
| Hospital Bed Capacity | 1 | 2020 | 1300 | 0.12 | Why? |
| Hemophilia A | 1 | 2017 | 362 | 0.11 | Why? |
| Gestational Age | 1 | 2017 | 1488 | 0.11 | Why? |
| Genome-Wide Association Study | 1 | 2018 | 1648 | 0.11 | Why? |
| Rats | 1 | 2019 | 2764 | 0.11 | Why? |
| Immune System | 1 | 2021 | 1479 | 0.11 | Why? |
| Aftercare | 1 | 2021 | 1637 | 0.11 | Why? |
| Male | 17 | 2021 | 367725 | 0.11 | Why? |
| Intubation, Intratracheal | 1 | 2006 | 3962 | 0.11 | Why? |
| Female | 16 | 2021 | 380317 | 0.10 | Why? |
| Case-Control Studies | 3 | 2018 | 17671 | 0.10 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.10 | Why? |
| Mice | 2 | 2021 | 21357 | 0.10 | Why? |
| Infant, Newborn | 3 | 2018 | 23105 | 0.09 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2019 | 2483 | 0.09 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.09 | Why? |
| Hemodynamics | 1 | 2017 | 1562 | 0.09 | Why? |
| Polymorphism, Genetic | 1 | 2016 | 1074 | 0.09 | Why? |
| Brazil | 3 | 2021 | 12582 | 0.09 | Why? |
| Poverty | 1 | 2020 | 2302 | 0.09 | Why? |
| Schizophrenia | 1 | 2018 | 1018 | 0.09 | Why? |
| Patient Discharge | 2 | 2021 | 5696 | 0.09 | Why? |
| Heparin | 1 | 2021 | 2600 | 0.09 | Why? |
| Cross-Sectional Studies | 4 | 2019 | 53120 | 0.08 | Why? |
| Leukocyte Count | 1 | 2017 | 3178 | 0.08 | Why? |
| Adolescent | 6 | 2021 | 86841 | 0.08 | Why? |
| Disease Progression | 4 | 2017 | 13580 | 0.08 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.08 | Why? |
| Follow-Up Studies | 3 | 2019 | 17020 | 0.07 | Why? |
| Renal Dialysis | 3 | 2019 | 4358 | 0.07 | Why? |
| Conscious Sedation | 1 | 2006 | 222 | 0.07 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.07 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.07 | Why? |
| Prospective Studies | 2 | 2019 | 43301 | 0.06 | Why? |
| Child, Preschool | 4 | 2021 | 36283 | 0.06 | Why? |
| Liver | 1 | 2017 | 4007 | 0.06 | Why? |
| Infant | 3 | 2021 | 30274 | 0.06 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.06 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 7868 | 0.06 | Why? |
| Interleukin-6 | 1 | 2019 | 7522 | 0.05 | Why? |
| Glomerular Filtration Rate | 2 | 2017 | 1262 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2019 | 10998 | 0.05 | Why? |
| Ultrasonography | 1 | 2017 | 4409 | 0.05 | Why? |
| Kidney Transplantation | 1 | 2021 | 5397 | 0.05 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2016 | 5993 | 0.05 | Why? |
| Immunohistochemistry | 2 | 2017 | 2275 | 0.05 | Why? |
| C-Reactive Protein | 1 | 2016 | 7972 | 0.05 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.05 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.05 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.04 | Why? |
| Time Factors | 2 | 2017 | 31397 | 0.04 | Why? |
| Cell-Derived Microparticles | 1 | 2017 | 134 | 0.04 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2016 | 238 | 0.04 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.04 | Why? |
| Double-Blind Method | 1 | 2006 | 5988 | 0.04 | Why? |
| Thrombosis | 1 | 2017 | 7504 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2019 | 11497 | 0.03 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.03 | Why? |
| Hemostasis | 1 | 2016 | 811 | 0.02 | Why? |
| Adult | 5 | 2019 | 244371 | 0.02 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Research | 1 | 2020 | 2115 | 0.02 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.02 | Why? |
| Epithelial Cells | 1 | 2017 | 3508 | 0.02 | Why? |
| Aged | 1 | 2021 | 215776 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2021 | 8495 | 0.02 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.01 | Why? |
| Middle Aged | 4 | 2019 | 270681 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Retrospective Studies | 2 | 2017 | 105322 | 0.01 | Why? |
| Prognosis | 1 | 2017 | 32490 | 0.01 | Why? |
| Pandemics | 1 | 2020 | 389249 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.01 | Why? |
Simões E Silva's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(166)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(56)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_